Principal Investigator
Eugene Schiff
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20211116
Clinical Trial Summary
A Phase 2, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Study Evaluating the Safety and Efficacy of Semaglutide, and the Fixed-Dose Combination of Cilofexor and Firsocostat, Alone and in Combination, in Subjects with Compensated Cirrhosis (F4) due to Nonalcoholic Steatohepatitis (NASH)
Phase
Phase II
Funding Agency/Sponsor
Industry
Disease
NASH (Non-Alcoholic SteatoHepatitis)
Contact Information
Study Contact
Sonia Carvalho
Phone Number
+1 (305) 2434639
Email
scarvalho@miami.edu